LifeStance Health (LFST) CTO sells 44,394 shares under 10b5-1 plan

Rhea-AI Filing Summary

LifeStance Health Group, Inc. Chief Technology Officer Vukasin Paunovich reported selling 44,394 shares of common stock on August 10, 2026, at $10.85 per share in an open market or private transaction. After this transaction, he directly holds 247,446 shares. The transaction is flagged as made pursuant to a Rule 10b5-1 trading plan, indicating it was executed under a pre-arranged plan.

Insider Trade Summary 10b5-1

Net Seller: 44,394 shares

Net Sell 1 txn

Insider Paunovich Vukasin

Role Chief Technology Officer

Sold 44,394 shs ($482K)

Type	Security	Shares	Price	Value
Sale	Common Stock	44,394	$10.85	$482K

Holdings After Transaction: Common Stock — 247,446 shares (Direct)

Key Figures

Shares sold: 44,394 shares Sale price per share: $10.85 per share Shares held after transaction: 247,446 shares

3 metrics

Shares sold 44,394 shares Common stock sale on August 10, 2026

Sale price per share $10.85 per share Price for the August 10, 2026 common stock sale

Shares held after transaction 247,446 shares Direct holdings of CTO after the reported sale

Key Terms

Rule 10b5-1 trading plan, Common Stock, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The transaction is flagged as made pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Common Stock financial

"reported selling 44,394 shares of common stock on August 10, 2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

What insider transaction did LifeStance Health (LFST) report for its CTO?

LifeStance Health’s CTO, Vukasin Paunovich, reported a sale of 44,394 common shares on August 10, 2026, at $10.85 per share. Following the transaction, he directly holds 247,446 shares of LifeStance Health common stock.

Was the recent LFST insider sale by the CTO under a Rule 10b5-1 plan?

Yes. The CTO’s reported sale of 44,394 shares of LifeStance Health common stock was designated as occurring under a Rule 10b5-1 trading plan, indicating the trade was executed according to a pre-established trading arrangement.

How many LifeStance Health (LFST) shares does the CTO hold after the sale?

After selling 44,394 shares on August 10, 2026, the CTO directly holds 247,446 shares of LifeStance Health common stock. This post-transaction holding reflects the position reported in the insider ownership data.

What price did the LifeStance Health (LFST) CTO receive per share in the sale?

The CTO’s reported sale of 44,394 shares of LifeStance Health common stock was executed at a price of $10.85 per share. The transaction is classified as a sale in an open market or private transaction.

What is the nature of ownership reported for the LFST CTO’s remaining shares?

The filing shows the CTO’s 247,446 shares of LifeStance Health common stock as held with direct ownership. No indirect ownership entities or special ownership nature descriptions are referenced for this transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 05:07 PM Accepted by SEC EDGAR 08/12/2026 - 05:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Paunovich Vukasin

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		S		44,394	D	$10.85	247,446	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Ryan Pardo, Attorney-in-Fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)